CD99 was also found to be highly expressed in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and stem cells and anti-CD99 monoclonal antibodies show antileukemic activity in AML xenograft models (19–21). Here, CD99 is linked to myelodysplastic syndrome.